Aminoferrocene-Based Prodrugs and Their Effects on Human Normal and Cancer Cells as Well as Bacterial Cells
- 26 August 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (17) , 6935-6944
Abstract
Aminoferrocene-based prodrugs are activated under cancer-specific conditions (high concentration of reactive oxygen species, ROS) with the formation of glutathione scavengers (p-quinone methide) and ROS-generating iron complexes. Herein, we explored three structural modifications of these prodrugs in an attempt to improve their properties: (a) the attachment of a −COOH function to the ferrocene fragment leads to the improvement of water solubility and reactivity in vitro but also decreases cell-membrane permeability and biological activity, (b) the alkylation of the N-benzyl residue does not show any significant affect, and (c) the attachment of the second arylboronic acid fragment improves the toxicity (IC50) of the prodrugs toward human promyelocytic leukemia cells (HL-60) from 52 to 12 μM. Finally, we demonstrated that the prodrugs are active against primary chronic lymphocytic leukemia (CLL) cells, with the best compounds exhibiting an IC50 value of 1.5 μM. The most active compounds were found to not affect mononuclear cells and representative bacterial cells.Keywords
This publication has 45 references indexed in Scilit:
- Redox activation of metal-based prodrugs as a strategy for drug deliveryAdvanced Drug Delivery Reviews, 2012
- ROS‐Inducible DNA Cross‐Linking Agent as a New Anticancer Prodrug Building BlockChemistry – A European Journal, 2012
- Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer ProdrugsJournal of the American Chemical Society, 2011
- Chemistry and Biology of Deoxynyboquinone, a Potent Inducer of Cancer Cell DeathJournal of the American Chemical Society, 2010
- Caged mitochondrial uncouplers that are released in response to hydrogen peroxideTetrahedron, 2010
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nature Reviews Drug Discovery, 2009
- A Targetable Fluorescent Probe for Imaging Hydrogen Peroxide in the Mitochondria of Living CellsJournal of the American Chemical Society, 2008
- Molecular imaging of hydrogen peroxide produced for cell signalingNature Chemical Biology, 2007
- Synthesis and Investigation of New Macrocyclic Diphosphine−Palladium(0) Complexes Based on the Barbiturate Binding ReceptorOrganometallics, 2002
- Vitamin K3 (menadione) inhibits the growth of mammalian tumor cells in cultureLife Sciences, 1981